C4 Therapeutics Inc. (CCCC)
NASDAQ · Healthcare
C4 Therapeutics Inc. Cash on Hand 2021–2025
C4 Therapeutics Inc. annual cash on hand history from 2021 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- C4 Therapeutics Inc. cash on hand as of December 31, 2025: 74.6M, a 34.42% increase year-over-year.
- C4 Therapeutics Inc. cash on hand for 2025 were 74.6M, a 34.42% increase from 2024.
- C4 Therapeutics Inc. cash on hand for 2024 were 55.5M, a 56.16% decrease from 2023.
- C4 Therapeutics Inc. cash on hand for 2023 were 126.6M, a 325.46% increase from 2022.
- C4 Therapeutics Inc. cash on hand for 2022 were 29.8M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| C4 Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $75 |
| 2024 | $55 |
| 2023 | $127 |
| 2022 | $30 |
| 2021 | $76 |
C4 Therapeutics Inc. Cash on Hand — FAQ
C4 Therapeutics Inc. (CCCC) cash on hand over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CCCC's cash on hand history?
The chart and table above show C4 Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.